Honglei Wang
- Molecular Biology
- Cancer Research top 10%
- Cell Biology top 10%
- Health, Toxicology and Mutagenesis top 10%
- Immunology
- Topics
- MicroRNA in disease regulation (7 papers)Circular RNAs in diseases (5 papers)Parkinson's Disease Mechanisms and Treatments (4 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Honglei Wang
34 papers receiving 823 citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 373
- Cancer Research 263
- Cell Biology 149
- Health, Toxicology and Mutagenesis 124
- Immunology 103
Countries citing papers authored by Honglei Wang
This map shows the geographic impact of Honglei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Wang more than expected).
Fields of papers citing papers by Honglei Wang
This network shows the impact of papers produced by Honglei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Wang. The network helps show where Honglei Wang may publish in the future.
Co-authorship network of co-authors of Honglei Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Honglei Wang. A scholar is included among the top collaborators of Honglei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglei Wang. Honglei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 0 | |
| 9 | 15 | |
| 10 | 6 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 90 | |
| 15 | 70 | |
| 16 | 50 | |
| 17 | 4 | |
| 18 | 32 | |
| 19 | 16 | |
| 20 | 193 |
About Honglei Wang
Honglei Wang is a scholar working on Cancer Research, Cell Biology and Geriatrics and Gerontology, having authored 38 papers that have together received 829 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Cancer Research (263 citations), Cell Biology (149 citations) and Health, Toxicology and Mutagenesis (124 citations). Honglei Wang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Wujian Peng, Xin Ouyang, Yong Dai, Wuxian Li, Zhen Meng, Zigang Cao, Xinjun Liao, Liqun Zhou, Huiqiang Lu and Shouhua Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.